Last reviewed · How we verify
NCT03557528
Role of Low Inferior Mesenteric Artery Ligation During Laparoscopic Surgery for Rectosigmoid Cancer
trial testing Laparoscopic colorectal resection in Rectosigmoid Adenocarcinoma in 120 participants. Completed in 30 April 2017.
31 December 2016
Quick facts
| Lead sponsor | University of Roma La Sapienza |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 1 January 2014 |
| Primary completion | 31 December 2016 |
| Estimated completion | 30 April 2017 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Laparoscopic colorectal resection
Conditions studied
- Rectosigmoid Adenocarcinoma — all drugs for Rectosigmoid Adenocarcinoma →
Sponsor
University of Roma La Sapienza
Who can join
Eligibility, any sex, with Rectosigmoid Adenocarcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
During sigmoid or rectal cancer surgery, dissection of lymphnodes at the origin of inferior mesenteric artery is mandatory. Nevertheless, ligation of the origin of IMA should compromise blood supply to left colon and affect anastomosis. The aim of this retrospective evaluation is to compare high and low IMA ligation with preservation of LCA, with or without skeletonization of the origin of IMA in laparoscopic colorectal resection.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03557528
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Laparoscopic colorectal resection
Trials testing the same drug.
- NCT05164887 — Microbiota Implementation to Reduce Anastomotic Colorectal Leaks (MIRACLe) · completed
Other recruiting trials for Rectosigmoid Adenocarcinoma
Currently open trials in the same condition.
- NCT02874885 — Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer · active not recruiting
Other University of Roma La Sapienza trials
Trials by the same sponsor.
- NCT07485023 — Oral Versus Intravenous Iron for Anemia Diagnosed After 34 Weeks of Gestation · NA · not yet recruiting
- NCT07305519 — The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin · NA · not yet recruiting
- NCT07520968 — ABX Versus CHX in NSPT: a RCT · NA · active not recruiting
- NCT07109596 — Integration of Clinical, Biological and Psycho-social Variables for a Gender-sensitive Frailty Prediction · recruiting
- NCT07490574 — Trial of Underwater Versus Gas-Insufflation Colorectal Endoscopic Submucosal DisseEtion · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03557528 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Roma La Sapienza
- Last refreshed: 15 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03557528.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing